Clough Capital Partners L P Vertex Pharmaceuticals Inc Transaction History

Clough Capital Partners L P

$924 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $3.3 Million - $3.69 Million	-10,480 Reduced 28.7%	26,041 $9.16 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $3.03 Million - $3.45 Million	-10,690 Reduced 22.64%	36,521 $11.5 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $9.3 Million - $10.5 Million	32,530 Added 221.58%	47,211 $13.6 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $429,913 - $479,682	-1,570 Reduced 9.66%	14,681 $4.25 Million
Q2 2022 Aug 16, 2022	SELL	$234.96 - $292.55 $9.84 Million - $12.3 Million	-41,899 Reduced 72.05%	16,251 $4.58 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $10.8 Million - $12.8 Million	-48,960 Reduced 45.71%	58,150 $15.2 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $3.1 Million - $3.91 Million	17,500 Added 19.53%	107,110 $23.5 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $1.56 Million - $1.84 Million	8,330 Added 10.25%	89,610 $18.1 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $1.1 Million - $1.28 Million	-5,320 Reduced 6.14%	81,280 $17.5 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $2.34 Million - $3.12 Million	11,290 Added 14.99%	86,600 $20.5 Million
Q3 2020 Nov 17, 2020	BUY	$255.65 - $303.1 $11.4 Million - $13.6 Million	44,710 Added 146.11%	75,310 $20.5 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $2.54 Million - $3.33 Million	-11,250 Reduced 26.88%	30,600 $8.88 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $1.02 Million - $1.27 Million	5,110 Added 13.91%	41,850 $9.96 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $999,593 - $1.34 Million	5,996 Added 19.5%	36,740 $8.04 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $49,869 - $56,127	-300 Reduced 0.97%	30,744 $5.21 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $4.51 Million - $5.22 Million	-27,405 Reduced 46.89%	31,044 $5.69 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $2.24 Million - $2.66 Million	13,660 Added 30.5%	58,449 $10.8 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $140,212 - $177,409	-923 Reduced 2.02%	44,789 $7.42 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $922,515 - $1.06 Million	-5,500 Reduced 10.74%	45,712 $8.81 Million
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $1.14 Million - $1.33 Million	-7,830 Reduced 13.26%	51,212 $8.7 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $1.01 Million - $1.18 Million	-6,640 Reduced 10.11%	59,042 $9.62 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $384,384 - $435,540	2,800 Added 4.45%	65,682 $9.84 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $9.31 Million - $10.2 Million	62,882	62,882 $9.56 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Account